# 唾石症治疗市场 > 腺石症治疗市场研究报告，按治疗类型（药物、外科手术、微创手术、体外冲击波碎石术）、按最终用户（医院、专科诊所、门诊手术中心）、按给药途径（口服、注射、外用）、按患者人口统计（成人、儿童、老年人）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.71% - **2024:** $ 1.45 Billion - **2025:** $ 1.52 Billion - **2035:** $ 2.4 Billion - **Key Players:** Johnson & Johnson (US), Medtronic (US), Stryker Corporation (US), Boston Scientific (US), Smith & Nephew (GB), B. Braun Melsungen AG (DE), Halyard Health (US), ConMed Corporation (US), Olympus Corporation (JP) **Report ID:** MRFR/HC/37513-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/sialolithiasis-treatment-market-39517 --- ## Market Summary ## **Sialolithiasis Treatment Market Overview** As per MRFR analysis, the Sialolithiasis Treatment Market Size was estimated at 1.45 USD Billion in 2024. The Sialolithiasis Treatment Market Industry is expected to grow from 1.51 USD Billion in 2025 to 2.29 USD Billion till 2034, at a CAGR growth rate is expected to be around 4.71% during the forecast period from 2025 to 2034. ### **Key Sialolithiasis Treatment Market Trends Highlighted** Sialolithiasis Treatment Market is observing robust growth on account of increasing cases of salivary gland stones, accompanied with increasing awareness about oral health. Some of the topmost market drivers include growing incidence of sialolithiasis, which is determined by lifestyles such as dietary intake and enzymatic secretion due to dehydration. Furthermore, the potential benefits of development in advanced minimally invasive techniques and technologies like endoscopic procedures have become of great interest and are improving the treatment and bringing more patients. More investments in research and development are also enhancing the growth of the market by improving the alternatives of treatment. The opportunities available in the sialolithiasis treatment market are quite some, especially with the improvements in access to health systems in the developing countries. It may be possible to design personalized therapy regimens for patients. Such regimens can influence treatment success. There is also an increased demand for education on strategies to prevent diseases so patients can learn to recognize symptoms and seek treatment at appropriate times. Companies may seek collaborative relationships with professionals in order to help patients obtain more advanced therapies. Also, recent developments indicate that sialolithiasis treatment has been expanding in the scope of its practice, combining dental, medical, and surgical aspects into a single treatment process. This in turn is facilitating the enhancement of care and medical outcomes for patients. Furthermore, there is a growing number of digital health technologies intended for diagnosis and management, signalling a shift toward a technological approach in health care. The emergence of new market segments for online resources is expected to accelerate the development of the market efforts which need to be focused on the availability of information and the involvement of patients in the processes associated with their treatment. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Sialolithiasis Treatment Market Drivers** ### **Increasing Prevalence of Sialolithiasis** The Sialolithiasis Treatment Market Industry is significantly driven by the rising prevalence of sialolithiasis, commonly known as salivary gland stones. This condition affects a sizable portion of the population, and the increasing incidence can be attributed to various factors such as dehydration, dietary habits, and underlying health issues. As more individuals are diagnosed with this condition, the demand for effective treatment options rises accordingly. The treatment landscape for sialolithiasis includes both conservative measures and advanced surgical options, thereby expanding accessibility and patient awareness. Additionally, the growing number of healthcare facilities equipped with modern technology for the diagnosis and treatment of sialolithiasis contributes to market growth. Patients are also becoming more informed about their treatment options, leading to increased consultations and a shift towards seeking professional help. Therefore, both the increasing diagnosis rates and the enhanced treatment options available in the market are expected to play a crucial role in driving the Sialolithiasis Treatment Market forward in the coming years. ### **Advancements in Treatment Technologies** The Sialolithiasis Treatment Market Industry is witnessing accelerated growth due to significant advancements in treatment technologies. Innovations such as minimally invasive surgical procedures, laser therapy, and ultrasound-guided techniques are revolutionizing how sialolithiasis is treated. These advanced technologies not only ensure higher success rates but also minimize complications and recovery times. As a result, patient satisfaction and healthcare providers' preference for these advanced treatments are boosting market growth significantly. Additionally, research and development activities aimed at creating new therapeutic options are continuously contributing to the evolving treatment landscape. ### **Growing Investment in Healthcare Infrastructure** The Sialolithiasis Treatment Market Industry benefits from the increasing investment in healthcare infrastructure across various regions. Governments and private players are focusing on enhancing healthcare facilities, which includes the establishment of specialized ENT centers and dental clinics aimed at providing comprehensive care for salivary gland disorders. This infrastructure growth leads to better diagnostic and treatment options, making it easier for patients to access necessary care. Furthermore, improved healthcare infrastructure often correlates with a higher rate of disease awareness among the general population, leading to early diagnosis and treatment, thus driving the demand for sialolithiasis treatments. ### **Sialolithiasis Treatment Market Segment Insights** #### **Sialolithiasis Treatment Market Treatment Type Insights** The Sialolithiasis Treatment Market is advancing steadily with a focus on diverse treatment types aimed at addressing the ailment effectively. In 2023, the overall market was valued at 1.32 USD Billion, highlighting consistent interest in effective treatment solutions. Among the various treatment types, Medication holds a majority share, valued at 0.55 USD Billion in 2023, and is projected to rise to 0.85 USD Billion by 2032, demonstrating its essential role in managing Sialolithiasis. Its significant demand can be attributed to patients' preference for non-invasive approaches, which enable symptom management and facilitate the dissolution of salivary stones. Following Medication, Surgical Procedures are valued at 0.35 USD Billion in 2023 and are expected to reach 0.5 USD Billion by 2032, reflecting a vital option for cases involving larger or obstructive stones that require physical removal. The growing awareness and advancements in surgical techniques contribute to this segment's robustness. Minimally Invasive Procedures, valued at 0.25 USD Billion in 2023 and expected to grow to 0.4 USD Billion by 2032, represent an evolving trend, combining efficiency with reduced recovery times. This segment’s significance is underscored by the increasing preference for treatments that involve less trauma and quicker recovery for patients. Extracorporeal Shock Wave Lithotripsy, with a current value of 0.17 USD Billion in 2023, is expected to grow to 0.25 USD Billion by 2032; though it captures a smaller market share, its non-invasive nature is advantageous for certain patients, facilitating stone fragmentation without surgical intervention. The various treatment types collectively reflect a well-rounded approach to tackling Sialolithiasis, driven by trends favoring less invasive options and advancements in medical technology. The Sialolithiasis Treatment Market revenue thereby showcases the growing focus on patient preferences and effectiveness across treatment modalities, with an overall market thesis centered on innovation and accessibility in treatment options. Market growth is further propelled by the rising incidence of salivary stones and an enhanced understanding of treatment dynamics, leading to opportunities for further research and development within these treatment types. The Sialolithiasis Treatment Market statistics reflect diverse treatment strategies to cater to varying patient needs, suggesting a promising landscape as the industry evolves. #### **Sialolithiasis Treatment Market End User Insights** The Sialolithiasis Treatment Market is expected to experience a steady growth trajectory, with significant contributions from diverse end-users. In 2023, the overall market will be valued at 1.32 billion USD, and hospitals will play a pivotal role in this segment by providing comprehensive treatment facilities and advanced medical solutions for sialolithiasis. Specialty clinics also significantly influence this market due to their focused approach and specialized care, addressing patients' unique needs in sialolithiasis management effectively. Meanwhile, ambulatory surgical centers are becoming increasingly significant as they offer cost-effective and efficient treatment options, catering to patients who prefer outpatient care. Each of these end-users contributes uniquely to the Sialolithiasis Treatment Market revenue, thus driving growth, enhanced accessibility, and improved patient outcomes. The market is poised to leverage trends like technological advancements and increasing awareness, promoting further expansion across these end-user categories. The overall emphasis is on optimizing treatment experiences and enhancing recovery processes in a segment that continues to evolve in response to patient demands. #### **Sialolithiasis Treatment Market Route of Administration Insights** The Sialolithiasis Treatment Market has shown a notable focus on the Route of Administration, which significantly influences treatment approaches and patient outcomes. In 2023, this market was valued at 1.32 billion USD, reflecting the growing demand for effective solutions for sialolithiasis. The market is segmented into Oral, Injectable, and Topical administration, with Oral administration holding a significant share due to its ease of use and patient compliance. Injectable options, while more invasive, are crucial for providing rapid relief and are often preferred in emergency care settings. Topical administration, on the other hand, presents a unique alternative, particularly for localized symptoms, though it holds a smaller market share. The diversity in routes of administration caters to varying patient needs, driving growth within the industry. The Sialolithiasis Treatment Market statistics indicate a steady transformation with increasing advancements in formulation and delivery mechanisms. Moreover, market growth is propelled by the rising prevalence of sialolithiasis, heightened awareness, and ongoing research aimed at novel treatments. However, challenges such as regulatory hurdles and varying reimbursement policies may impact growth trajectories and market dynamics. #### **Sialolithiasis Treatment Market Patient Demographics Insights** The Sialolithiasis Treatment Market is poised for significant growth, with a market valuation reaching 1.32 billion USD in 2023 and expected to increase substantially over the next few years. Patient Demographics play a crucial role in the market dynamics, as the treatment needs vary across different age groups. Adults represent a major portion of the market, often facing unique challenges related to lifestyle and health conditions that necessitate diverse treatment methods. Meanwhile, Pediatrics demand specialized approaches due to the anatomical differences and developmental considerations in younger patients, highlighting the importance of tailored treatment plans. Furthermore, geriatrics are also a significant demographic, experiencing higher incidences of sialolithiasis that are often aligned with age-related health issues, which contributes to the overall enlargement of the market. The growth of the Sialolithiasis Treatment Market is influenced by various factors, including an aging population, increasing awareness of preventive healthcare, and advancements in treatment technologies. Nonetheless, challenges such as varying healthcare access and treatment costs could impact market penetration. Overall, the Sialolithiasis Treatment Market data emphasizes how understanding these demographics is essential for strategizing effective treatments and maximizing market potential. #### **Sialolithiasis Treatment Market Regional Insights** The Regional segment of the Sialolithiasis Treatment Market exhibits noteworthy valuations and growth potential. In 2023, North America led this segment, holding a market revenue of 0.54 USD Billion and is projected to rise to 0.8 USD Billion by 2032, highlighting its dominant position due to advanced healthcare infrastructure and high treatment awareness. Europe follows, with a market value of 0.4 USD Billion in 2023, expected to grow to 0.6 USD Billion, reflecting strong demand for innovative treatment solutions. The APAC region, valued at 0.24 USD Billion in 2023, shows significant growth opportunities, projected to reach 0.36 USD Billion by 2032, driven by an increasing population and rising prevalence of sialolithiasis. South America and the MEA are comparatively smaller markets, with valuations of 0.08 USD Billion and 0.06 USD Billion in 2023, respectively, marking them as emerging markets with potential for healthcare advancements. The Sialolithiasis Treatment Market data suggest that while North America and Europe dominate, the trends reveal increasing investments and developments in the APAC region, creating new opportunities and challenges in treatment accessibility. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Sialolithiasis Treatment Market Key Players and Competitive Insights** The Sialolithiasis Treatment Market is characterized by a diverse array of strategies focusing on innovative medical devices and treatment methodologies to target salivary gland stones effectively. As this market expands, competitive insights reveal a landscape where companies leverage advanced technologies, engage in strategic partnerships, and invest in research and development to provide enhanced therapeutic options. The growing prevalence of sialolithiasis, driven by lifestyle changes and dietary factors, is compelling industry players to explore new solutions to address pain relief, treatment efficiency, and patient satisfaction, necessitating a keen understanding of market dynamics and competitor positioning. Terumo Corporation stands out in the Sialolithiasis Treatment Market due to its robust commitment to innovation and quality. The company boasts a strong portfolio of medical devices that are designed to facilitate the effective removal of salivary stones. With an emphasis on safety and efficacy, Terumo Corporation utilizes cutting-edge technology and rigorous clinical trials to ensure its products meet the diverse needs of healthcare professionals and patients alike. Their established market presence, combined with a reputation for reliable and durable solutions, creates a competitive edge that is further enhanced by strategic collaborations with healthcare facilities and practitioners to optimize treatment protocols. Stryker is also a significant player in the Sialolithiasis Treatment Market, and it is known for its dedication to advancing surgical technologies and instrumentation. The company leverages its extensive experience in minimally invasive procedures, which translates into effective solutions for sialolithiasis treatment. Stryker’s approach incorporates innovative surgical tools and techniques that align with the latest medical guidelines, allowing clinicians to achieve better patient outcomes. Their strong emphasis on training and support for medical professionals further solidifies their presence in the market, showcasing a commitment to enhancing surgical techniques and improving recovery times for patients affected by salivary gland stones. ### **Key Companies in the Sialolithiasis Treatment Market Include** - Terumo Corporation - Stryker - Abbott Laboratories - MediTech - Koninklijke Philips - Cardinal Health - Baxter International - Edwards Lifesciences - Olympus Corporation - [Halyard Health](https://products.halyardhealth.com/products) - Braun Melsungen - Boston Scientific - Siemens Healthineers - Medtronic - Johnson and Johnson ### **Sialolithiasis Treatment Market Industry Developments** The Sialolithiasis Treatment Market is witnessing notable developments, particularly with advancements in minimally invasive procedures and technologies. Companies such as Terumo Corporation and Stryker are focusing on innovative devices that enhance patient experience and recovery times. Current affairs indicate an increased prevalence of sialolithiasis, driving demand for effective treatment solutions. Notably, Abbott Laboratories and Medtronic are exploring collaborations to develop new therapeutic options, leveraging their expertise in healthcare technologies. Recent mergers and acquisitions have added momentum to the market, with companies like Boston Scientific exploring strategic partnerships to expand their product portfolios. Additionally, growth in market valuation of players like Olympus Corporation and Siemens Healthineers is indicative of a robust increase in investment towards research and development, particularly in non-invasive treatment modalities. This competitive landscape aims to improve outcomes for patients suffering from sialolithiasis while enhancing operational efficiencies for manufacturers. As these firms focus on integrating cutting-edge technologies, the overall market is positioned for growth, responding to the rising demand for innovative treatment solutions. ### **Sialolithiasis Treatment Market Segmentation Insights** #### **Sialolithiasis Treatment Market Treatment Type Outlook** - Medication - Surgical Procedures - Minimally Invasive Procedures - [Extracorporeal Shock Wave Lithotripsy](../../../reports/extracorporeal-shock-wave-lithotripsy-market-42221) #### **Sialolithiasis Treatment Market End User Outlook** - Hospitals - Specialty Clinics - Ambulatory Surgical Centers #### **Sialolithiasis Treatment Market Route of Administration Outlook** - Oral - Injectable - Topical #### **Sialolithiasis Treatment Market Patient Demographics Outlook** - Adults - Pediatrics - Geriatrics #### **Sialolithiasis Treatment Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### 唾石症发病率上升 唾石症的日益普遍是唾石症治疗市场的一个显著驱动因素。脱水、饮食习惯和某些医疗条件等因素促成了唾液结石的形成。最近的研究表明，唾石症的发生率正在上升，估计每年大约有1/1000的人可能受到影响。这一不断增长的患者群体需要有效的治疗选择，从而推动了对创新疗法和外科干预的需求。随着医疗服务提供者寻求应对这一上升趋势，市场可能会见证旨在改善患者结果的新治疗方式的涌现。 ### 提高意识和患者教育 对患者教育和对唾液腺结石的认识的重视，正在成为唾液腺结石治疗市场的重要驱动力。医疗机构和专业人士的宣传活动增加，导致对这种疾病、其症状和可用治疗选项的理解得到了改善。这种提高的意识鼓励个人更早寻求医疗帮助，可能导致更早的诊断和治疗。因此，随着更多患者了解他们的选择，唾液腺结石治疗的需求可能会增加。此外，教育倡议可能会促进对与唾液腺结石相关的风险因素的主动管理，从而进一步影响唾液腺结石治疗市场的动态。 ### 治疗选择中的技术进步 技术创新在塑造腮石症治疗市场中发挥着至关重要的作用。微创技术的出现，如腮腺镜检查，彻底改变了唾液结石的管理。这些进展不仅提高了取石的精确度，还减少了与传统外科方法相关的恢复时间和并发症。此外，激光技术在腮石症治疗中的应用显示出良好的效果，提升了患者的满意度。随着这些技术的不断发展，预计将通过提供更安全、更有效的治疗替代方案来推动市场增长，从而吸引医疗服务提供者和患者进入腮石症治疗市场。 ### 增加对医疗基础设施的投资 医疗基础设施的投资是腮石症治疗市场的关键驱动力。各国政府和私营实体正日益增加资源，以提升医疗设施并改善对先进医疗技术的获取。这一趋势在医疗系统正在发展以满足对专业治疗日益增长的需求的地区尤为明显。增强的基础设施促进了腮石症创新治疗方式的采用，包括先进的诊断工具和外科技术。随着医疗系统的不断扩展和现代化，腮石症治疗市场有望增长，为患者提供更好的护理获取和更广泛的治疗选择。 ### 老龄化人口及相关健康问题 老龄化人口是影响腺石症治疗市场的一个关键人口因素。随着个体年龄的增长，他们可能会经历各种健康问题，包括脱水和唾液流量减少，这些都是腺石症的已知风险因素。世界卫生组织预测，到2050年，全球60岁及以上人口的比例将翻一番，这将导致老年人中腺石症的发病率增加。这一人口结构的变化可能会推动对针对老年患者需求的有效治疗方案的需求。因此，医疗服务提供者可能会专注于在腺石症治疗市场中开发专门的疗法，以应对这一人群面临的独特挑战。 ## Future Outlook 腮石症治疗市场预计将在2024年至2035年间以4.71%的年均增长率增长，推动因素包括发病率的增加和治疗技术的进步。 **New opportunities:** - 微创手术技术的发展 到2035年，市场预计将实现显著增长，反映出治疗方法的演变和患者获取的增加。 ## Segment Insights ### 按类型：药物（最大）与外科手术（增长最快） 在腺石症治疗市场中，该细分市场主要由药物主导，由于其广泛的可获得性和相较于其他治疗选项的低侵入性，药物占据了最大的市场份额。该细分市场包括各种药理学药物，帮助溶解结石或在移除过程中管理疼痛，并且在患者和医疗提供者中仍然是一个受欢迎的选择。另一方面，外科手术正在迅速增长，推动这一增长的是日益增加的复杂病例，这些病例需要直接干预。外科技术和技术的进步正在提高这些手术的有效性，导致市场动态的积极变化。 外科手术（主流）与微创手术（新兴） 外科手术在唾石症治疗市场中占据主导地位，因为它们在去除较大或位于困难区域的结石方面效果显著。这种传统方法包括多种技术，如腺体切除和导管探查，为持续的唾石症提供了明确的解决方案。然而，微创手术作为一种有吸引力的替代方案正在迅速崛起，其特点是恢复时间缩短和并发症发生率较低。随着患者寻求更少创伤的选择，内镜辅助碎石术等方法正在获得关注，这些方法承诺有效的结果，同时允许更快地恢复日常活动。因此，市场正在见证向创新、低侵入性治疗方式的偏好不断增长的转变。 ### 按最终用户：医院（最大）与门诊手术中心（增长最快） 在唾石症治疗市场中，终端用户的分布显示医院占据了最大的市场份额，因为它们传统上是提供全面唾石症治疗的主要设施。医院提供广泛的资源、先进的技术和多学科团队，这些都是管理复杂病例所必需的。专业诊所紧随其后，以其专注于特定治疗和以患者为中心的护理而闻名，而以高效和低成本著称的门诊手术中心正在迅速获得关注，满足越来越多寻求快速缓解症状的患者的需求。 医院（主导）与门诊手术中心（新兴） 医院是腮石症治疗市场的主导者，提供从诊断到外科干预的全方位服务。它们受益于既定的协议和丰富的医疗资源，通常导致更好的患者结果和更高的满意度。另一方面，门诊手术中心由于能够高效地进行手术，正在成为一个重要的细分市场，为患者提供更快的恢复时间和更低的费用。患者越来越倾向于选择这些中心，因为它们方便且住院时间较短，使其成为治疗领域的重要组成部分。 ### 按给药途径：口服（最大）与注射（增长最快） 在腺石症治疗市场中，给药途径部分包括口服、注射和局部措施。口服途径目前主导市场，占据了整体治疗方法的显著部分。注射方法因其日益被接受和使用而也颇具显著性，随后是局部治疗，尽管其市场份额较小，但满足了特定患者的需求。 给药途径：口服（主导）与注射（新兴） 口服给药被视为治疗唾液腺结石的主要方法，因为它对患者友好且方便。口服药物通常并发症较少，患者更容易遵从。相比之下，注射治疗因其快速作用和在急性病例中的有效性而逐渐受到关注。它们在寻求立即缓解疼痛和不适的患者中越来越受欢迎，显示出对更快治疗替代方案的日益偏好。随着研究的进展，创新的注射解决方案可能会增强其市场存在。 ### 按患者人口统计：成年人（最大）与老年人（增长最快） 唾石症治疗市场主要由成年群体驱动，该群体占寻求治疗的患者最大份额。成年人由于多种生活方式因素，包括饮食和脱水，常常出现唾石症，导致唾液石的形成。另一方面，老年人代表了一个新兴的细分市场，由于与年龄相关的唾腺功能自然下降，越来越多地被诊断为唾石症，使他们成为未来市场营销和治疗策略的重要关注领域。 成年人（主导）与老年人（新兴） 成年人仍然是腺石症治疗市场的主导人群，主要是由于饮食习惯、脱水和其他加重病情的健康问题等与生活方式相关的风险因素。该群体通常寻求对症腺石症的治疗，往往接受可预测且成熟的治疗程序。相反，老年人群体正迅速成为一个新兴的人口群体，因为医疗服务提供者认识到他们在腺石症方面面临的独特挑战，特别是唾液分泌能力降低和药物诱导的口干症的发生率增加。该细分市场的特点是需要量身定制的治疗方案，以应对他们特定的健康复杂性，突显了综合护理方法的重要性。 ## Regional Market Share Analysis ### 北美：创新的领先市场 北美是唾石症治疗的最大市场，占全球市场份额的约45%。该地区的增长受到先进医疗基础设施、唾石症发病率上升以及对研究和开发的强烈关注的推动。来自FDA等机构的监管支持进一步促进了市场扩展，确保创新治疗方案的可用性。美国在北美市场中处于领先地位，主要企业包括强生、美敦力和波士顿科学。竞争格局的特点是这些公司之间持续的创新和战略合作。加拿大也做出了重要贡献，越来越重视微创手术和以患者为中心的护理，增强了整体市场动态。 ### 欧洲：新兴的监管框架 欧洲是唾石症治疗的第二大市场，约占全球市场份额的30%。该地区受益于强大的医疗系统和对唾石症的日益关注，推动了对有效治疗方案的需求。监管框架，如欧洲药品管理局的指南，支持新疗法的引入，促进创新并改善患者结果。德国和英国是该市场的领先国家，B. Braun Melsungen AG和史密斯和内甫等公司做出了重要贡献。竞争格局的特点是成熟企业与专注于先进治疗方式的新兴初创企业的结合。医疗提供者与制造商之间的合作努力正在增强欧洲创新解决方案的可用性。 ### 亚太地区：快速增长的市场潜力 亚太地区是唾石症治疗市场的新兴强国，约占全球市场份额的20%。该地区的增长受到医疗支出上升、口腔健康意识提高和人口增长的推动。印度和中国等国正在见证对有效治疗方案的需求激增，政府倡导的改善医疗服务可及性和质量的举措也在支持这一趋势。中国和印度是该地区的主要市场，奥林巴斯公司和美敦力等主要企业的存在日益增强。竞争格局正在演变，地方制造商进入市场以满足日益增长的需求。对微创手术和技术进步的关注预计将进一步推动亚太地区唾石症治疗市场的增长。 ### 中东和非洲：未开发的市场机会 中东和非洲地区代表了一个未开发的唾石症治疗市场，约占全球市场份额的5%。该地区的增长受到医疗投资增加、对唾石症的认识提高和医疗基础设施改善的推动。各国政府正专注于改善医疗服务的可及性，预计这将在未来几年促进市场增长。南非和阿联酋等国在市场中处于领先地位，越来越多的医疗机构提供先进的治疗方案。竞争格局的特点是本地和国际企业的结合，Halyard Health和ConMed Corporation等公司正在扩大其市场份额。对患者教育和意识宣传活动的重视也在促进该地区唾石症治疗市场的增长。 ## Competitive Benchmarking 唾石症治疗市场的特点是一个竞争激烈的格局，越来越多地受到创新、战略合作伙伴关系和区域扩展的影响。像强生（美国）、美敦力（美国）和波士顿科学（美国）等主要参与者处于前沿，利用其广泛的研发能力来增强治疗方式。这些公司似乎专注于先进的微创技术和数字健康解决方案，这在满足患者需求和改善治疗结果方面变得至关重要。这些公司的集体战略表明，治疗方法正朝着更为综合的方向发展，技术与以患者为中心的护理相结合。 在商业策略方面，公司越来越多地本地化生产，以降低成本并提高供应链效率。这种方法在一个适度分散的市场中尤为相关，其中较小的参与者也为创新做出贡献。竞争结构表明，尽管大型企业占主导地位，但仍有大量小众参与者通过专业化产品颠覆传统做法。主要参与者的影响力很大，因为他们设定了质量和创新的基准，较小的公司往往努力达到这些标准。 在2025年8月，美敦力（美国）宣布推出一种新的唾石症治疗设备，该设备利用先进的成像技术来提高石头去除的精确度。这一战略举措表明美敦力对创新的承诺，并反映出将尖端技术整合到外科手术中的更广泛趋势。这种设备的推出可能会通过为医疗服务提供者提供改进的患者护理工具来增强美敦力的市场地位。 在2025年9月，波士顿科学（美国）扩大了与一家领先的远程医疗提供商的合作，以增强唾石症患者的远程监测能力。这一合作强调了数字健康解决方案在治疗领域日益重要的地位。通过整合远程医疗服务，波士顿科学旨在改善患者参与度和后续护理，这可能会导致更好的治疗依从性和结果。 在2025年7月，强生（美国）收购了一家专注于唾液腺疾病再生医学的小型生物技术公司。这一收购似乎是为了多样化其产品组合并增强其治疗唾石症的能力。通过整合再生疗法，强生可能会将自己定位为创新治疗选择的领导者，从而潜在地重塑市场的竞争动态。 截至2025年10月，唾石症治疗市场正在见证强调数字化、可持续性和人工智能在治疗方案中整合的趋势。战略联盟越来越多地塑造着市场格局，因为公司认识到合作在推动创新中的价值。竞争差异化可能会从传统的基于价格的竞争转向关注技术进步、以患者为中心的解决方案和可靠的供应链。这一转变表明，优先考虑创新和适应性的公司将在未来更具竞争力。 ## Recent News & Developments 腮石症治疗市场正在经历显著的发展，特别是在微创手术和技术方面的进步。诸如Terumo Corporation和Stryker等公司正专注于创新设备，以提升患者体验和恢复时间。 当前的事务表明腮石症的发病率增加，推动了对有效治疗方案的需求。值得注意的是，Abbott Laboratories和Medtronic正在探索合作，以开发新的治疗选择，利用他们在医疗技术方面的专业知识。最近的并购活动为市场增添了动力，像Boston Scientific这样的公司正在探索战略合作伙伴关系，以扩展其产品组合。 此外，Olympus Corporation和Siemens Healthineers等公司的市场估值增长，表明对研究和开发的投资显著增加，特别是在非侵入性治疗方式方面。这种竞争格局旨在改善腮石症患者的治疗效果，同时提高制造商的运营效率。 随着这些公司专注于整合尖端技术，整体市场正处于增长的有利位置，以响应对创新治疗方案日益增长的需求。 ## Report Scope | 2024年市场规模 | 1.447（十亿美元） | | --- | --- | | 2025年市场规模 | 1.515（十亿美元） | | 2035年市场规模 | 2.401（十亿美元） | | 复合年增长率（CAGR） | 4.71%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 微创技术的进步提升了腮石症治疗市场的患者结果。 | | 主要市场动态 | 对微创手术需求的增加推动了腮石症治疗选项和技术的创新。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，唾石症治疗市场的预计市场估值是多少？** A: 预计到2035年，唾石症治疗市场的市场估值为24.01亿美元。 **Q: 2024年唾石症治疗市场的整体市场估值是多少？** A: 2024年唾石症治疗市场的整体市场估值为14.47亿美元。 **Q: 在2025年至2035年的预测期内，唾石症治疗市场的预期CAGR是多少？** A: 在2025年至2035年的预测期内，唾石症治疗市场的预期年复合增长率（CAGR）为4.71%。 **Q: 在唾石症治疗市场中，哪些公司被视为关键参与者？** A: 在唾石症治疗市场的主要参与者包括强生公司、美敦力、史赛克公司和波士顿科学。 **Q: 唾石症治疗市场的主要细分领域是什么？** A: 唾石症治疗市场的主要细分包括类型、最终用户、给药途径和患者人口统计。 **Q: 2024年外科手术部门的表现如何？** A: 在2024年，外科手术部门的估值为4亿美元，预计到2035年将达到6.5亿美元。 **Q: 在腮腺结石治疗市场中，医院部门的估值范围是多少？** A: 医院部门在2024年的估值为7.24亿美元，预计到2035年将增长至12.24亿美元。 **Q: 到2035年，注射给药途径的预计增长是多少？** A: 注射给药途径预计将从2024年的4亿美元增长到2035年的6.5亿美元。 **Q: 在唾石症治疗市场中，哪个人口细分显示出最高的估值？** A: 成人群体的细分市场显示出最高的估值，预计在2024年为8亿美元，到2035年达到13亿美元。 **Q: 微创手术的效果与其他治疗类型相比如何？** A: 微创手术细分市场在2024年的估值为3亿美元，预计到2035年将达到5.5亿美元，显示出稳定的增长。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/sialolithiasis-treatment-market-39517*